Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS2R38 | P59533 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5534526 | 0.77 | — | — | |
| SCHEMBL901448 | 0.72 | — | — | |
| SCHEMBL5264057 | 0.70 | — | — | |
| SCHEMBL10974723 | 0.70 | MEN1 (0.33) | TAS2R38 | |
| SCHEMBL9430606 | 0.69 | GRIN2D (0.41) | — | |
| SCHEMBL10975324 | 0.68 | CA1 (0.47) | — | |
| SCHEMBL9366477 | 0.68 | SPHK1 (0.41) | — | |
| SCHEMBL10977190 | 0.68 | ALDH1A1 (0.38) | — | |
| SCHEMBL10978888 | 0.68 | ALDH1A1 (0.41) | TAS2R38 | |
| SCHEMBL9430433 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5512588-A | ANTIULCER AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-30 | — | — | US | disclosed |
| EP-0598906-A1 | FURYLTHIAZOLE AND THEIR USE AS H 2?-RECEPTOR ANTAGONISM AND ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-01 | — | — | EP | disclosed |
| WO-1994003450-A1 | FURYLTHIAZOLE AND THEIR USE AS H2-RECEPTOR ANTAGONISTS AND ANTIMICROBIAL AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-02-17 | — | — | WO | disclosed |
| WO-1993003028-A1 | FURYLTHIAZOLE AND THEIR USE AS H2-RECEPTOR ANTAGONISM AND ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-18 | — | — | WO | disclosed |